In vitro activities of the novel oxazolidinones DA-7867 and DA-7157 against rapidly and slowly growing mycobacteria

Antimicrobial Agents and Chemotherapy

Volumn 50, Issue 12, 2006, Pages 4027-4029

  Vera Cabrera, Lucio ^a   Brown Elliott, Barbara A ^b   Wallace Jr , Richard J ^b   Ocampo Candiani, Jorge ^a   Welsh, Oliverio ^a   Sung, Hak Choi ^c   Molina Torres, Carmen A ^a  

^a HOSPITAL UNIVERSITARIO DR JOSÉ ELEUTERIO GONZÁLEZ   (Mexico)

^b UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

^c Dong A Pharmaceutical Company   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

3 [4 [2 (2 METHYLTETRAZOL 5 YL)PYRIDIN 5 YL] 3 FLUOROPHENYL] 5 HYDROXYMETHYLOXAZOLIDIN 2 ONE; DA 7157; DA 7867; LINEZOLID; N [3 [4 [2 (1 METHYL 5 TETRAZOLYL)PYRIDIN 5 YL] 3 FLUOROPHENYL] 2 OXO 5 OXAZOLIDINYL]METHYLACETAMIDE; OXAZOLIDINONE DERIVATIVE;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIUM CULTURE; BACTERIUM ISOLATE; BROTH MICRODILUTION ASSAY; CULTURE MEDIUM; DILUTION; DRUG EFFECT; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; NOCARDIA; NONHUMAN; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; HUMANS; INDICATOR DILUTION TECHNIQUES; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM; MYCOBACTERIUM AVIUM COMPLEX; MYCOBACTERIUM CHELONAE; MYCOBACTERIUM FORTUITUM; MYCOBACTERIUM KANSASII; MYCOBACTERIUM MARINUM; OXAZOLES; OXAZOLIDINONES; TETRAZOLES;

EID: 33845238462     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00763-06     Document Type: Article

References (18)

1. Andries, K., P. Verhasselt, J. Guillemont, H. W. Gohlmann, J. M. Neefs, H. Winkler, J. Van Gestel, P. Timmerman, M. Zhu, E. Lee, P. Williams, D. de Chaffoy, E. Huitric, S. Hoffner, E. Cambau, C. Truffot-Pernot, N. Lounis, and V. Jarlier. 2005. A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis. Science 307:223-227.
2. Brown-Elliott, B. A., R. J. Wallace, Jr., R. Blinkhorn, C. J. Crist, and L. B. Mann. 2001. Successful treatment of disseminated Mycobacterium chelonae infection with linezolid. Clin. Infect. Dis. 33:1433-1434.
3. Brown-Elliott, B. A., C. J. Crist, L. B. Mann, R. W. Wilson, and R. J. Wallace, Jr. 2003. In vitro activity of linezolid against slowly growing non-tuberculous mycobacteria. Antimicrob. Agents Chemother. 47:1736-1738.
4. De Groote, M. A., and G. Huitt. 2006. Infections due to rapidly growing mycobacteria. Clin. Infect. Dis. 42:1756-1763.
5. Field, S. K., D. Fisher, and R. L. Cowie. 2004. Mycobacterium avium complex pulmonary disease in patients without HIV infection. Chest 126:566-581.
6. Fortun, J., P. Martin-Davila, E. Navas, M. J. Perez-Elias, J. Cobo, M. Tato, E. G. De la Pedrosa, E. Gomez-Mampaso, and S. Moreno. 2005. Linezolid for the treatment of multidrug-resistant tuberculosis. J. Antimicrob. Chemother. 56:180-185.
7. Moylett, E. H., S. E. Pacheco, B. A. Brown-Elliott, T. R. Perry, E. S. Buescher, M. C. Birmingham, J. J. Schentag, J. F. Gimbel, A. Apodaca, M. A. Schwartz, R. M. Rakita, and R. J. Wallace, Jr. 2003. Clinical experience with linezolid for the treatment of nocardia infection. Clin. Infect. Dis. 36:313-318.
8. Nannini, E. C., M. Keating, P. Binstock, G. Samonis, and D. P. Kontoyiannis. 2002. Successful treatment of refractory disseminated Mycobacterium avium complex infection with the addition of linezolid and mefloquine. J. Infect. 44:201-203.
9. National Committee for Clinical Laboratory Standards. 2003. Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes; approved standard. NCCLS document M24-A. National Committee for Clinical Laboratory Standards, Wayne, Pa.
10. Protopopova, M., C. Hanrahan, B. Nikonenko, R. Samala, P. Chen, J. Gearhart, L. Einck, and C. A. Nacy. 2005. Identification of a new antitubercular drug candidate, SQ109, from a combinatorial library of 1,2-ethylenediamines. J. Antimicrob. Chemother. 56:968-974.
11. Shinabarger, D. 1999. Mechanism of action of the oxazolidinone antibacterial agents. Expert Opin. Investig. Drugs 8:1195-1202.
12. Telenti, A., F. Marchesi, M. Balz, F. Bally, E. C. Bottger, and T. Bodmer. 1993. Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis. J. Clin. Microbiol. 31:175-178.
13. Tortoli, E. 2003. Impact of genotypic studies on mycobacterial taxonomy: the new mycobacteria of the 1990s. Clin. Microbiol. Rev. 16:319-354.
14. Vera-Cabrera, L., E. Y. Ochoa-Felix, G. Gonzalez, R. Tijerina, S. H. Choi, and O. Welsh. 2004. In vitro activities of new quinolones and oxazolidinones against Actinomadura madurae. Antimicrob. Agents Chemother. 48:1037-1039.
15. Vera-Cabrera, L., E. Gonzalez, A. Rendon, J. Ocampo-Candiani, O. Welsh, V. M. Velazquez-Moreno, S. H. Choi, and C. Molina-Torres. 2006. In vitro activities of DA-7157 and DA-7218 against Mycobacterium tuberculosis and Nocardia brasiliensis. Antimicrob. Agents Chemother. 50:3170-3172.
16. Vera-Cabrera, L., E. Gonzalez, S. H. Choi, and O. Welsh. 2004. In vitro activities of new antimicrobials against Nocardia brasiliensis. Antimicrob. Agents Chemother. 48:602-604.
17. Wallace, R. J., Jr., B. A. Brown-Elliott, S. C. Ward, C. J. Crist, L. B. Mann, and R. W. Wilson. 2001. Activities of linezolid against rapidly growing mycobacteria. Antimicrob. Agents Chemother. 45:764-767.
18. Yang, S. C., P. R. Hsueh, H. C. Lai, L. J. Teng, L. M. Huang, J. M. Chen, S. K. Wang, D. C. Shie, S. W. Ho, and K. T. Luh. 2003. High prevalence of antimicrobial resistance in rapidly growing mycobacteria in Taiwan. Antimicrob. Agents Chemother. 47:1958-1962.